… develop and implement pharmacological treatments for this condition. … aneurysm segment,
antithrombotic therapies have emerged as potential pharmaceutical agents for the treatment …

… certainty evidence that antiplatelet therapy is not associated with a reduced growth rate for
infrarenal aortic aneurysms (AAAs) under surveillance. Antiplatelet therapy was associated …

… of thrombus in an aortic aneurysm, or in an endograft following endovascular aneurysm
repair, have been studied, but the role of antiplatelet therapy in those two conditions is still …

… Importance Patients with abdominal aortic aneurysm have a high risk of ischemic events …
recommend antiplatelet therapy to mitigate this risk. However, in patients with aneurysms …

… This suggests that such treatment may protect against acute aortic syndromes, though … aortic
rupture never survive to receive this medical therapy, as antiplatelet therapy following aortic …

… that antithrombotic therapy influences the sac behavior after EVAR. Antiplatelet therapy was
… Moreover, antiplatelet and anticoagulant therapies were identified as risk factors for late …

… patients on antiplatelet agents or not receiving antithrombotic therapy. However, information
regarding baseline ILT volume and thickness before antithrombotic therapy or aneurysm …

… repair (EVAR) compares favorably with open abdominal aortic aneurysm (AAA) repair in
terms of 30-day mortality and duration of intensive care stay. In comparison to open AAA repair, …

… Despite it is generally considered unsafe to administer anticoagulants in patients with TBAD,
we present a case in which triple antithrombotic therapy was well tolerated and did not lead …

… on aortic aneurysmal disease advise that all patients should be started on antiplatelet therapy
at … receiving an aortic endograft should be kept on the best medical treatment, including …